Granix (tbo-filgrastim) is used to raise (low white blood cell (WBC) count) caused by anticancer medications. It's very similar to the medication Neupogen (filgrastim), but not quite the same. Granix (tbo-filgrastim) is injected under the skin daily until WBC levels are within normal range, for up to 2 weeks at a time. The most common side effect of medications like Granix (tbo-filgrastim) is bone pain. Currently there's no generic version available, only brand name.
Granix (tbo-filgrastim) is a granulocyte colony-stimulating factor (G-CSF). It works like the naturally occurring G-CSF protein in your body to stimulate (trigger) bone marrow to make neutrophils, which is a type of white blood cell that helps your body fight infection.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Granix (tbo-filgrastim) is usually given when your WBCs called neutrophils are very low. You can have low neutrophils as a side effect of receiving chemotherapy medications. Having low neutrophils) raises your risk of infection, and some people develop a serious condition called febrile neutropenia.
Your provider will typically order blood work for you about twice a week and before chemotherapy. You can expect your WBC level to rise over time. In clinical studies, people usually saw their WBC level return to normal range after 5 to 14 days of Granix (tbo-filgrastim).
Granix (tbo-filgrastim) is not a true biosimilar of Neupogen (filgrastim), but it's still very similar. While Neupogen (filgrastim) is used to prevent low white blood cell count during different treatments, Granix (tbo-filgrastim) is only FDA approved to prevent low white blood cell count during chemotherapy. Talk to your provider to find out which medication is right for you.
You'll need to wait at least 24 hours after chemotherapy before starting Granix (tbo-filgrastim) to prevent the risk of the chemotherapy causing damage to the new WBCs. There have been research that showed that starting Granix (tbo-filgrastim) too soon after chemotherapy might make it more difficult for WBC levels to recover.
If you're not experiencing any serious side effects, your provider will likely have you continue your Granix (tbo-filgrastim) injections until your WBC count returns to normal. In clinical trials, this typically took 5 days to 2 weeks. You'll receive Granix (tbo-filgrastim) for a maximum of 2 weeks at a time. It's important to keep regularly scheduled labs, so your provider can monitor your WBC levels. Don't stop Granix (tbo-filgrastim) without first talking to your provider.
Granix (tbo-filgrastim) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
There have been rare cases of people having enlarged (larger than normal) spleens while taking Granix (tbo-filgrastim). In serious cases, the spleen can rupture (break open), which can be deadly. Contact your provider if you notice any pain in the upper left stomach area or in your shoulder.
Granix (tbo-filgrastim) can cause a serious breathing condition, where fluid builds up in your lungs, called acute respiratory distress syndrome (ARDS). Get medical help right away if you have a fever and trouble breathing.
Sickle cell crisis (painful episode) has occurred in people with sickle cell anemia while receiving Granix (tbo-filgrastim). If this happens, If this happens, your healthcare provider will stop the medication.
Kidney damage can happen in people people taking Granix (tbo-filgrastim). Your provider will monitor your labs and can lower your dose or pause the medication if they suspect kidney problems. The kidney damage will usually get better if it's the medication causing the problem. Let your provider know if you notice blood in your urine, which can be a sign of kidney problems.
G-CSF medications like Granix (tbo-filgrastim) can cause capillary leak syndrome (CLS). CLS is a serious condition where blood leaks out of your small blood vessels. Low blood pressure is a common sign, but CLS can also be seen in certain lab tests. Talk to your provider if you experience dizziness, light headedness, or swelling in your hands and feet
Granix (tbo-filgrastim) is a growth factor, which means there's a possibility for it to make other types of tumors (myeloid cell lines) grow. Talk with your provider if you have questions about Granix (tbo-filgrastim) and the risk of cancer growth.
Granix (tbo-filgrastim) can cause serious allergic reactions, which can be life threatening if not treated. Don't take Granix (tbo-filgrastim) if you've ever had an allergic reaction to it or a similar medication like Neulasta (pegfilgrastim). Make sure your healthcare team always has an up to date list of your allergies.
Some people receiving filgrastim products like Granix (tbo-filgrastim) have reported developing a condition caused by inflammation of blood vessels called aortitis. This condition could happen as early as the first week after starting treatment. Let your provider know if you experience fever, stomach pain, back pain, or feel unwell so you can be checked out.
Granix (tbo-filgrastim) is usually started at least 24 hours after chemotherapy. The typical dose is 5 mcg/kg of body weight per day given as a subcutaneous (under the skin) injection until your WBC count is within normal range. The maximum duration of treatment is 2 weeks.
Prevention of low neutrophil-related complications in:
Preparation for blood collection for your own stem cell transplant (Neupogen, Nivestym, and Zarxio only)
Increase survival in people exposed to bone marrow-suppressing radiation (Neupogen only)